Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a biopharmaceutical company focusing on developing novel therapies for metabolic and endocrine disorders.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Viking Therapeutics' stock, anticipating it could rise significantly in value.
Financial Health
Viking Therapeutics is showing strong financial performance with healthy cash flow and book value.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring VKTX
Cardio-Metabolic Drugs: Beyond Weight Loss Benefits
Following new data showing Novo Nordisk's Wegovy has superior cardiovascular benefits over a key rival, the competitive landscape for weight-loss drugs has intensified. This theme focuses on the pharmaceutical giants battling for dominance and the innovative biotechs whose research in related metabolic and cardiovascular fields is now more valuable than ever.
Published: September 1, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline Catalysts Ahead
Clinical trial readouts and regulatory milestones can materially move the stock, offering potential opportunities but also significant downside if results disappoint.
Growth & Volatility
Market capitalisation reflects expectations for future success; small‑cap biotech shares can swing widely, so consider risk tolerance and investment horizon.
Competitive Landscape
Metabolic and liver disease are active areas with competing approaches; regulatory and commercial dynamics will influence long‑term prospects.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
